Cargando…

A human SARS-CoV neutralizing antibody against epitope on S2 protein

An immune antibody phage-display library was constructed from B cells of SARS convalescent patients. More than 80 clones were selected from the library by using the whole inactivated SARS-CoV virions as target. One human scFv, B1, was characterized extensively. The B1 recognized SARS pseudovirus in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Jinzhu, Yan, Xiyun, Guo, Xueming, Cao, Wuchun, Han, Wei, Qi, Cai, Feng, Jing, Yang, Dongling, Gao, Guangxia, Jin, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092839/ https://www.ncbi.nlm.nih.gov/pubmed/15939399 http://dx.doi.org/10.1016/j.bbrc.2005.05.089

Ejemplares similares

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
por: Xue, Jun-biao, et al.
Publicado: (2021)

Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes
por: Gattinger, Pia, et al.
Publicado: (2021)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
por: Deshpande, Ashlesha, et al.
Publicado: (2021)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes
por: Fu, Dan, et al.
Publicado: (2021)

Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2
por: Lim, Shion A., et al.
Publicado: (2021)

Protective neutralizing epitopes in SARS‐CoV‐2
por: Liu, Hejun, et al.
Publicado: (2022)

SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites
por: Yang, Li, et al.
Publicado: (2022)

The immunodominant and neutralization linear epitopes for SARS-CoV-2
por: Lu, Shuai, et al.
Publicado: (2021)

Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein
por: Zhong, Lilin, et al.
Publicado: (2009)

Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
por: Bianchini, Filippo, et al.
Publicado: (2022)

Non-neutralizing antibodies to SARS-Cov-2-related linear epitopes induce psychotic-like behavior in mice
por: Xu, Jinming, et al.
Publicado: (2023)

Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response
por: Su, Qiu-Dong, et al.
Publicado: (2021)

Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
por: Li, Yang, et al.
Publicado: (2020)

Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting
por: Lim, Hui Xuan, et al.
Publicado: (2022)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants
por: Lin, Wei-Shuo, et al.
Publicado: (2021)

A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD
por: Liu, Shuo, et al.
Publicado: (2022)

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
por: Zhou, Guangyu, et al.
Publicado: (2020)

Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2
por: Li, Lili, et al.
Publicado: (2022)

Seropositive Reaction Rates of 9 B-Cell Epitopes of the SARS-CoV-2 Spike Protein and the Relationship between the Epitopes and Neutralizing Antibody
por: Zhu, Li, et al.
Publicado: (2021)

Proteome-wide epitope mapping identifies a resource of antibodies for SARS-CoV-2 detection and neutralization
por: Liang, Te, et al.
Publicado: (2021)

Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
por: Changrob, Siriruk, et al.
Publicado: (2021)

Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2
por: Zhou, Xiaojuan, et al.
Publicado: (2021)

Cross neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike
por: Wilson, Patrick, et al.
Publicado: (2021)

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
por: Rouet, Romain, et al.
Publicado: (2023)

Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
por: Bianchini, Filippo, et al.
Publicado: (2023)

Perspectives on the development of neutralizing antibodies against SARS-CoV-2
por: Ho, Mitchell
Publicado: (2020)

Development of superior antibodies against the S-protein of SARS-Cov-2 using macrocyclic epitopes
por: Traboulsi, Hassan, et al.
Publicado: (2022)

Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
por: Zhou, Yunjiao, et al.
Publicado: (2021)

An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif
por: Fang, Yan, et al.
Publicado: (2022)

Correction for Xiong et al., The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
Publicado: (2022)

Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2
por: Hotop, Sven-Kevin, et al.
Publicado: (2022)

Functional epitopes and neutralizing antibodies of vaccinia virus
por: Peng, Fenghao, et al.
Publicado: (2023)

Antibodies Targeting Two Epitopes in SARS-CoV-2 Neutralize Pseudoviruses with the Spike Proteins from Different Variants
por: Yang, Chee-Hing, et al.
Publicado: (2021)

Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
por: Yamamoto, Shinya, et al.
Publicado: (2023)

Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants
por: Li, Lili, et al.
Publicado: (2022)

Potently neutralizing and protective human antibodies against SARS-CoV-2
por: Zost, Seth J., et al.
Publicado: (2020)

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
por: Jiang, Shibo, et al.
Publicado: (2020)

The development of neutralizing antibodies against SARS-CoV-2 and their common features
por: Liu, Liu Daisy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_59qat58nb2shh9h1c4lh8t4f5g